Our preliminary study suggested that IJH-SONE68 also has an anti-obesity effect, and therefore, lipid metabolism and fatty liver might be improved during the trial, resulting in the decrease of ALT and ChE. Here, GPT is linked to obesity due to melanocortin 4 receptor deficiency.